Skip to main content

Vaccine maker got $1B from taxpayers. Now it’s boosting drug prices

By Los Angeles Times  
   September 14, 2020

WASHINGTON — One of the world's largest drug companies has been aggressively raising prices even as it received hundreds of millions of dollars of U.S. government aid to develop a COVID-19 vaccine.

Full story


Get the latest on healthcare leadership in your inbox.